Skip to content

Retrospective identification of microvascular and pericyte alterations and establishment of these as morphological biomarkers in interstitial lung diseases

Retrospective identification of microvascular and pericyte alterations and establishment of these as morphological biomarkers in interstitial lung diseases

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00040766
Enrollment
600
Registered
2026-06-25
Start date
2024-03-13
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

interstitial lung diseases, lung transplant tissue, and COVID-19 lung tissue

Interventions

Group 1: Histological and biological samples as well as radiological and clinical data from patients with: 1. Interstitial lung disease (ILD) 2. Lung transplantation tissue -additional control tissue

Sponsors

Pathologisches Institut
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: - Histological Tissue • Histopathologically diagnosed interstitial lung disease, lung transplant tissue, or COVID-19 autopsy cases (positive control: altered lung parenchyma of the affected lung lobes / negative control: non-altered lung parenchyma of the unaffected lung lobes of the same patients) - Biological Samples • Presence of signed informed consent from the Thorax Biobank Heidelberg or the Hannover Unified Biobank (HUB) - Radiological and Clinical Data • Radiologically or clinically diagnosed interstitial lung disease, lung transplantations, or COVID-19 cases.

Exclusion criteria

Exclusion criteria: - Histological Tissue • Routine diagnostics have not yet been completed. • Reuse of the tissue for future diagnostic procedures cannot be excluded. • No biomaterial available or insufficient biomaterial available. - Biological Samples • Withdrawal of informed consent. - Radiological and Clinical Data • Routine diagnostics have not yet been completed.

Design outcomes

Primary

MeasureTime frame
The primary objective of the study is to identify microvascular and pericyte alterations in histological tissue from patients with interstitial lung disease (ILD) and to establish them as novel diagnostic markers for routine histopathological assessment.

Secondary

MeasureTime frame
Secondary objectives include the identification of diagnostically relevant vascular and angiogenesis-related protein expression patterns, as well as the correlation of histological, clinical, and radiological data sets.

Countries

Germany

Contacts

Public ContactCleo-Aron Weis

Pathologisches Institut

cleo-aron.weis@uni-heidelberg.de+4962215637817

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Aug 10, 2026